Medpace Holdings, Inc. Quarterly Depreciation in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Medpace Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q3 2015 to Q3 2024.
  • Medpace Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $7.16M, a 13.1% increase year-over-year.
  • Medpace Holdings, Inc. Depreciation for the twelve months ending September 30, 2024 was $27.1M, a 19% increase year-over-year.
  • Medpace Holdings, Inc. annual Depreciation for 2023 was $24.1M, a 27.1% increase from 2022.
  • Medpace Holdings, Inc. annual Depreciation for 2022 was $19M, a 18.6% increase from 2021.
  • Medpace Holdings, Inc. annual Depreciation for 2021 was $16M, a 37.4% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $27.1M $7.16M +$829K +13.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-22
Q2 2024 $26.3M $6.87M +$904K +15.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-23
Q1 2024 $25.4M $6.63M +$1.22M +22.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-23
Q4 2023 $24.1M $6.42M +$1.36M +26.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $22.8M $6.33M +$1.38M +27.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-22
Q2 2023 $21.4M $5.97M +$1.26M +26.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-23
Q1 2023 $20.1M $5.41M +$1.14M +26.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-23
Q4 2022 $19M $5.06M +$875K +20.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $18.1M $4.95M +$895K +22.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-24
Q2 2022 $17.2M $4.71M +$756K +19.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 $16.5M $4.27M +$458K +12% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 $16M $4.19M +$652K +18.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $15.4M $4.06M +$1.07M +35.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 $14.3M $3.95M +$1.28M +47.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-26
Q1 2021 $13M $3.81M +$1.36M +55.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q4 2020 $11.7M $3.53M +$1.21M +52% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-14
Q3 2020 $10.4M $2.99M +$929K +45.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-26
Q2 2020 $9.51M $2.67M +$692K +34.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q1 2020 $8.82M $2.45M +$462K +23.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-27
Q4 2019 $8.36M $2.33M -$32K -1.36% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 $8.39M $2.06M -$281K -12% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-27
Q2 2019 $8.67M $1.98M -$244K -11% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 $8.92M $1.99M -$323K -14% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $9.24M $2.36M +$251K +11.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $8.99M $2.34M +$106K +4.74% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-29
Q2 2018 $8.88M $2.23M +$125K +5.95% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $8.76M $2.31M +$184K +8.64% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q4 2017 $8.57M $2.11M +$145K +7.39% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $8.43M $2.24M +$322K +16.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $8.11M $2.1M +$308K +17.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $7.8M $2.13M +$357K +20.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 $7.44M $1.96M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $1.92M +$304K +18.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $1.79M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $1.77M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q3 2015 $1.61M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.